In 2023, under the Biden Administration, 19 peptides were removed from the list of substances that US compounding pharmacies can legally prepare due to safety concerns
Close Monitoring: Our healthcare professionals will closely monitor your progress and any side effects, ensuring a smooth and effective transition to tirzepatide
Ipiter Iuppiter littera "Observations on the littera rule" (PDF)
doi: 10.1080/15563650.2017.1291945 [PubMed] 29423816 Yarema M, Chopra P, Sivilotti MLA, Johnson D, Nettel-Aguirre A, Bailey B, Victorino C, Gosselin S, Purssell R, Thompson M, Spyker D, Rumack B
Primary research: Neuroprotection, cellular survival, age-related cognitive decline Mechanism: Activates STAT3 signaling, inhibits Bax-mediated apoptosis, and interacts with IGFBP-3 Regulatory status: Not FDA-approved
2010 May 18 [cited 2022 Mar 24];3(1):19